氧嗪酸钾联合不同造模剂对小鼠高尿酸血症的尿酸值的影响

摘要
图/表
参考文献(24)
相关文章 (15)

全文: PDF (0 KB) HTML (40 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨氧嗪酸钾联合不同造模剂对小鼠高尿酸血症（HUA）尿酸值的影响，为早期HUA 的防治和药物筛选提供参考。方法采用300 mg/kg 氧嗪酸钾、500 mg/kg 尿酸、500 mg/kg 次黄嘌呤、250 mg/kg 乙胺丁醇多个造模剂，对ICR 小鼠进行HUA 造模，通过不同时间段取血测定尿酸值，比较不同造模因素对血尿酸的影响。结果给予300 mg/kg 氧嗪酸钾能使小鼠尿酸水平升高，但是不能维持尿酸的高水平状态；给予300 mg/kg 氧嗪酸钾联合500 mg/kg 尿酸溶液能使血尿酸水平升高，且上升幅度较大（上升幅度为207.2%），但同样不能维持尿酸的高水平状态；给予300 mg/kg 氧嗪酸钾联合500 mg/kg 次黄嘌呤溶液能使血尿酸水平升高，且上升幅度较大（上升幅度为384.4%），但同样不能维持尿酸的高水平状态；给予300 mg/kg 氧嗪酸钾联合250 mg/kg 乙胺丁醇溶液能使血尿酸水平升高，上升幅度较大（上升幅度为320.8%），且能稳定维持尿酸在高水平的状态。结论氧嗪酸钾联合乙胺丁醇可成功使ICR 小鼠尿酸值升高，并稳定维持尿酸的水平，造模效果优于单独的氧嗪酸钾、氧嗪酸钾联合尿酸、氧嗪酸钾联合次黄嘌呤。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	韩铨
	王昱植
	付国峰
	郭璐
	胡柳
	吴妍
	沈妍

关键词 ：高尿酸血症, 尿酸, 次黄嘌呤, 氧嗪酸钾, 乙胺丁醇

Abstract：Objective To explore the effect of potassium oxonate combined with different modeling agents on the uric acid value of mice with hyperuricemia(HUA),and provide reference for early prevention and treatment of HUA and drug screening.Methods HUA was modeled in ICR mice with 300 mg/kg potassium oxonate,500 mg/kg uric acid,500 mg/kg hypoxanthine and 250 mg/kg ethambutol.Blood samples were taken at different time periods to determine the uric acid value to compare the effects of different modeling factors on blood uric acid.Results The adminwastration of 300 mg/kg potassium oxonate could increase the level of uric acid,but could not maintain the high level of uric acid.The administration of 300 mg/kg potassium oxonate combined with 500 mg/kg uric acid solution could increase the level of uric acid in blood(the increase rate was 207.2%),but the high level of uric acid could not be maintained.The administration of 300 mg/kg potassium oxonate combined with 500 mg/kg hypoxanthine solution could increase the serum uric acid level(the increase rate was 384.4%),but the high level of uric acid could not be maintained either.The administration of 300 mg/kg potassium oxonate combined with 250 mg/kg ethambutol solution could increase the serum uric acid level(the increase rate was 320.8%),and the high level of uric acid could be maintained stably.Conclusion The combination of potassium oxazinate and ethambutol could successfully increase the uric acid value of ICR mice and stably maintain the level of uric acid.The modeling effect was better than that of single potassium oxonate,potassium oxonate combined with uric acid and oxygen,potassium oxonate combined with hypoxanthine.

Key words： Hyperuricemia Uric acid Hypoxanthine Potassium oxonate Ethambutol

引用本文:

韩铨;王昱植;付国峰;郭璐;胡柳;吴妍;沈妍. 氧嗪酸钾联合不同造模剂对小鼠高尿酸血症的尿酸值的影响[J]. 中国当代医药, 2021, 28(18): 21-25.
HAN Quan ;WANG Yu-zhi ;FU Guo-feng ;GUO Lu ;HU Liu ;WU Yan; SHEN Yan. Effect of potassium oxonate combined with different modelling agents on the uric acid value of hyperuricemia in mice. 中国当代医药, 2021, 28(18): 21-25.

链接本文:

http://dangdaiyiyao.com/CN/ 或 http://dangdaiyiyao.com/CN/Y2021/V28/I18/21

[1]	Li X，Yan Z，Carlstrom M，et al.Mangiferin Ameliorates Hyperuricemic Nephropathy Which was Associated With Downregulation of AQP2 and Increased Urinary Uric Acid Excretion[J].Front Pharmacol，2020，11：49.
[2]	Han B，Wang N，Chen Y，et al.Prevalence of hyperuricaemia in an Eastern Chinese population：a cross-sectional study[J].BMJ Open，2020，10（5）：e035614.
[3]	方卫纲，黄晓明，王玉，等.高尿酸血症在北京地区1997人中的患病情况及相关因素分析[J].中华医学杂志，2006，86（25）：1764-1768.
[4]	何青.高尿酸血症与心血管疾病[J].中国心血管杂志，2010，15（3）：169-169.
[5]	Wang S，Fang Y，Yu X，et al.The flavonoid-rich fraction from rhizomes of Smilax glabra Roxb.ameliorates renal oxidative stress and inflammation in uric acid nephropathy rats through promoting uric acid excretion[J].Biomed Pharmacother，2019，111：162-168.
[6]	刘杰，李琴，刘先俊，等.果糖与氧嗪酸钾联用建造高尿酸血症大鼠模型[J].基因组学与应用生物学，2018，37（2）：667-674.
[7]	Vandell AG，Mcdonough CW，Gong Y，et al.Hydrochlorothiazide-induced hyperuricaemia in the Pharmacogenomic Evaluation of Antihypertensive Responses（PEAR）study[J].J Intern Med，2014，276（5）：486-497.
[8]	Zhu Y，Peng X，Ling G.An update on the animal models in hyperuricaemia research[J].Clin Exp Rheumatol，2017，35（5），860-864.
[9]	吴燕升，万强，史丽强，等.高尿酸血症肾纤维化动物模型研究进展[J].成都医学院学报，2016，11（6）：747-750.
[10]	Mallat SG，Al Kattar S，Tanios BY，et al.Hyperuricemia，Hypertension，and Chronic Kidney Dwasease：an Emerging Association[J].Curr Hypertens Rep，2016，18（10）：74.
[11]	Vadakedath S，Kandi V.Probable Potential Role of Urate Transporter Genes in the Development of Metabolic Dwasorders[J].Cureus，2018，10（3）：e2382.
[12]	Park JE，Yeom Z，Park KT，et al.Hypouricemic Effect of Ethanol Extract of Aster glehni Leaves in Potassium oxonate-Induced Hyperuricemic Rats[J].Clin Nutr Res，2018，7（2）：126-135.
[13]	Lu J，Hou X，Yuan X，et al.Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic dwasorders[J].Kidney Int，2018，93（1）：69-80.
[14]	Tan PK，Farrar JE，Gaucher EA，et al.Coevolution of URAT1 and Uricase during Primate Evolution：Implications for Serum Urate Homeostaswas and Gout[J].Mol Biol Evol，2016，33（9）：2193-2200.
[15]	Oda M，Satta Y，Takenaka O，et al.Loss of urate oxidase activity in hominoids and its evolutionary implications[J].Mol Biol Evol，2002，19（5）：640-653.
[16]	Bobulescu IA，Moe OW.Renal transport of uric acid：evolving concepts and uncertainties[J].Adv Chronic Kidney Dwas，2012，19（6）：358-71.
[17]	Kaur P，Bhatt H.Hyperuricosuria[M].Treasure Island（FL）：StatPearls Publwashing，2020.
[18]	Fridovich I.The Competitive Inhibition of Uricase by Oxonate and by Related Derivatives of S-Triazines[J].J Biol Chem，1965，240：2491-2494.
[19]	王凯，夏德萌，郝晓伟，等.氧嗪酸钾诱导高尿酸血症小鼠血清代谢组学研究[J].药学服务与研究，2015，15（6）：416-421.
[20]	金沈锐，郑军，刘绍唐.小鼠高尿酸血症模型初探[J].成都中医药大学学报，1999，22（1）：49-50.
[21]	周子正，徐琳，高建东.高尿酸血症动物模型研究进展[J].医学综述，2020，26（8）：1462-1466.
[22]	冯学轩，刘月姝，饶子亮，等.急、慢性高尿酸血症模型的建立[J].中国比较医学杂志，2020，30（1）：74-80.
[23]	Zhu L，Dong Y，Na S，et al.Saponins extracted from Dioscorea collettii rhizomes regulate the expression of urate transporters in chronic hyperuricemia rats[J].Biomed Pharmacother，2017，93：88-94.
[24]	沈桂芹.降尿酸方对高尿酸血症大鼠作用机制的研究[D].沈阳：辽宁中医药大学，2018.